U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

2005
130
Substance Class Protein
Created
by admin
on Mon Mar 31 20:42:03 GMT 2025
Edited
by admin
on Mon Mar 31 20:42:03 GMT 2025
Protein Sub Type
Sequence Type COMPLETE
Record UNII
7GR9I2683O
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
RH-OLIGOPEPTIDE-2
INCI  
INCI  
Preferred Name English
MECASERMIN
EMA EPAR   INN   MART.   MI   USAN   VANDF   WHO-DD  
USAN   INN  
Official Name English
SH-OLIGOPEPTIDE-2
INCI  
INCI  
Preferred Name English
Mecasermin [WHO-DD]
Common Name English
PV-802
Common Name English
CG-IGF-1
Brand Name English
SOMATOMEDIN C, HUMAN
Common Name English
VEXXON-IGF-1
Brand Name English
BIO-FD&C IGF1
Brand Name English
SOMATOMEDIN C
Common Name English
MECASERMIN [EMA EPAR]
Common Name English
mecasermin [INN]
Common Name English
MECASERMIN [JAN]
Common Name English
INSULIN-LIKE GROWTH FACTOR I [MI]
Common Name English
NEXPURE PLANT-MADE IGF-1
Brand Name English
MECASERMIN [USAN]
Common Name English
INSULIN-LIKE GROWTH FACTOR 1
Common Name English
CG-GF2
Brand Name English
PV802
Common Name English
INSULIN-LIKE GROWTH FACTOR I
MI  
Common Name English
RECOMBINANT HUMAN INSULIN-LIKE GROWTH FACTOR-I
Common Name English
INSULIN-LIKE GROWTH FACTOR I (HUMAN)
Common Name English
INCRELEX
Brand Name English
MECASERMIN RECOMBINANT [ORANGE BOOK]
Common Name English
MECASERMIN [MART.]
Common Name English
MECASERMIN RECOMBINANT
ORANGE BOOK  
Common Name English
MECASERMIN [MI]
Common Name English
MYOTROPHIN
Brand Name English
CEP-151
Code English
MECASERMIN [VANDF]
Common Name English
Classification Tree Code System Code
FDA ORPHAN DRUG 249707
Created by admin on Mon Mar 31 20:42:03 GMT 2025 , Edited by admin on Mon Mar 31 20:42:03 GMT 2025
EU-Orphan Drug EU/3/06/373
Created by admin on Mon Mar 31 20:42:03 GMT 2025 , Edited by admin on Mon Mar 31 20:42:03 GMT 2025
FDA ORPHAN DRUG 90895
Created by admin on Mon Mar 31 20:42:03 GMT 2025 , Edited by admin on Mon Mar 31 20:42:03 GMT 2025
FDA ORPHAN DRUG 91995
Created by admin on Mon Mar 31 20:42:03 GMT 2025 , Edited by admin on Mon Mar 31 20:42:03 GMT 2025
FDA ORPHAN DRUG 93695
Created by admin on Mon Mar 31 20:42:03 GMT 2025 , Edited by admin on Mon Mar 31 20:42:03 GMT 2025
EMA ASSESSMENT REPORTS INCRELAX (AUTHORIZED: LARON SYNDROME)
Created by admin on Mon Mar 31 20:42:03 GMT 2025 , Edited by admin on Mon Mar 31 20:42:03 GMT 2025
FDA ORPHAN DRUG 59191
Created by admin on Mon Mar 31 20:42:03 GMT 2025 , Edited by admin on Mon Mar 31 20:42:03 GMT 2025
FDA ORPHAN DRUG 89795
Created by admin on Mon Mar 31 20:42:03 GMT 2025 , Edited by admin on Mon Mar 31 20:42:03 GMT 2025
FDA ORPHAN DRUG 128999
Created by admin on Mon Mar 31 20:42:03 GMT 2025 , Edited by admin on Mon Mar 31 20:42:03 GMT 2025
WHO-ATC H01AC03
Created by admin on Mon Mar 31 20:42:03 GMT 2025 , Edited by admin on Mon Mar 31 20:42:03 GMT 2025
DSLD 1469 (Number of products:4)
Created by admin on Mon Mar 31 20:42:03 GMT 2025 , Edited by admin on Mon Mar 31 20:42:03 GMT 2025
DSLD 1772 (Number of products:8)
Created by admin on Mon Mar 31 20:42:03 GMT 2025 , Edited by admin on Mon Mar 31 20:42:03 GMT 2025
LOINC 12252-3
Created by admin on Mon Mar 31 20:42:03 GMT 2025 , Edited by admin on Mon Mar 31 20:42:03 GMT 2025
FDA ORPHAN DRUG 871322
Created by admin on Mon Mar 31 20:42:03 GMT 2025 , Edited by admin on Mon Mar 31 20:42:03 GMT 2025
WHO-VATC QH01AC03
Created by admin on Mon Mar 31 20:42:03 GMT 2025 , Edited by admin on Mon Mar 31 20:42:03 GMT 2025
NCI_THESAURUS C835
Created by admin on Mon Mar 31 20:42:03 GMT 2025 , Edited by admin on Mon Mar 31 20:42:03 GMT 2025
FDA ORPHAN DRUG 856421
Created by admin on Mon Mar 31 20:42:03 GMT 2025 , Edited by admin on Mon Mar 31 20:42:03 GMT 2025
FDA ORPHAN DRUG 491915
Created by admin on Mon Mar 31 20:42:03 GMT 2025 , Edited by admin on Mon Mar 31 20:42:03 GMT 2025
Code System Code Type Description
IUPHAR
4971
Created by admin on Mon Mar 31 20:42:03 GMT 2025 , Edited by admin on Mon Mar 31 20:42:03 GMT 2025
PRIMARY
DAILYMED
7GR9I2683O
Created by admin on Mon Mar 31 20:42:03 GMT 2025 , Edited by admin on Mon Mar 31 20:42:03 GMT 2025
PRIMARY
MERCK INDEX
m7114
Created by admin on Mon Mar 31 20:42:03 GMT 2025 , Edited by admin on Mon Mar 31 20:42:03 GMT 2025
PRIMARY Merck Index
UNIPROT
P05019
Created by admin on Mon Mar 31 20:42:03 GMT 2025 , Edited by admin on Mon Mar 31 20:42:03 GMT 2025
PRIMARY
EPA CompTox
DTXSID7041049
Created by admin on Mon Mar 31 20:42:03 GMT 2025 , Edited by admin on Mon Mar 31 20:42:03 GMT 2025
PRIMARY
FDA UNII
7GR9I2683O
Created by admin on Mon Mar 31 20:42:03 GMT 2025 , Edited by admin on Mon Mar 31 20:42:03 GMT 2025
PRIMARY
SMS_ID
100000085465
Created by admin on Mon Mar 31 20:42:03 GMT 2025 , Edited by admin on Mon Mar 31 20:42:03 GMT 2025
PRIMARY
EVMPD
SUB08672MIG
Created by admin on Mon Mar 31 20:42:03 GMT 2025 , Edited by admin on Mon Mar 31 20:42:03 GMT 2025
PRIMARY
NCI_THESAURUS
C2262
Created by admin on Mon Mar 31 20:42:03 GMT 2025 , Edited by admin on Mon Mar 31 20:42:03 GMT 2025
PRIMARY
INN
6372
Created by admin on Mon Mar 31 20:42:03 GMT 2025 , Edited by admin on Mon Mar 31 20:42:03 GMT 2025
PRIMARY
ChEMBL
CHEMBL1201716
Created by admin on Mon Mar 31 20:42:03 GMT 2025 , Edited by admin on Mon Mar 31 20:42:03 GMT 2025
PRIMARY
DRUG CENTRAL
5009
Created by admin on Mon Mar 31 20:42:03 GMT 2025 , Edited by admin on Mon Mar 31 20:42:03 GMT 2025
PRIMARY
WIKIPEDIA
MECASERMIN
Created by admin on Mon Mar 31 20:42:03 GMT 2025 , Edited by admin on Mon Mar 31 20:42:03 GMT 2025
PRIMARY
CAS
67763-96-6
Created by admin on Mon Mar 31 20:42:03 GMT 2025 , Edited by admin on Mon Mar 31 20:42:03 GMT 2025
GENERIC (FAMILY)
CAS
68562-41-4
Created by admin on Mon Mar 31 20:42:03 GMT 2025 , Edited by admin on Mon Mar 31 20:42:03 GMT 2025
PRIMARY
MESH
C065700
Created by admin on Mon Mar 31 20:42:03 GMT 2025 , Edited by admin on Mon Mar 31 20:42:03 GMT 2025
PRIMARY
DRUG BANK
DB01277
Created by admin on Mon Mar 31 20:42:03 GMT 2025 , Edited by admin on Mon Mar 31 20:42:03 GMT 2025
PRIMARY
USAN
HH-78
Created by admin on Mon Mar 31 20:42:03 GMT 2025 , Edited by admin on Mon Mar 31 20:42:03 GMT 2025
PRIMARY
MERCK INDEX
m6299
Created by admin on Mon Mar 31 20:42:03 GMT 2025 , Edited by admin on Mon Mar 31 20:42:03 GMT 2025
PRIMARY Merck Index
RXCUI
274403
Created by admin on Mon Mar 31 20:42:03 GMT 2025 , Edited by admin on Mon Mar 31 20:42:03 GMT 2025
PRIMARY RxNorm
From To
1_6 1_48
1_18 1_61
1_47 1_52
Related Record Type Details
INSULIN-LIKE GROWTH FACTOR 1 RECEPTOR
TARGET -> AGONIST
INSULIN RECEPTOR
TARGET -> AGONIST
IGF-1 activates the insulin receptor at approximately 0.1x the potency of insulin.
DUSIGITUMAB
INHIBITOR -> TARGET
Related Record Type Details
MECASERMIN
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
Molecular Formula CHEMICAL
MOL_WEIGHT:SEQUENCE CHEMICAL
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966